Our previous research focused on elucidating the mechanisms by which A2AR regulates neuroinflammatory responses associated with CCH, with the ultimate goal of identifying strategies to alleviate the ensuing white matter damage in the brain. The gene discussed is ADORA2A; the disease is columnar cell hyperplasia of the breast.